Doximity Inc (NYSE: DOCS) has a price-to-earnings ratio that is above its average at 67.59x. The stock has a 36-month beta value of 1.39. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 2 as “overweight,” 13 as “hold,” and 0 as “sell.”
The public float for DOCS is 123.68M, and at present, short sellers hold a 4.76% of that float. On February 05, 2025, the average trading volume of DOCS was 2.07M shares.
DOCS) stock’s latest price update
Doximity Inc (NYSE: DOCS) has seen a decline in its stock price by -0.59 in relation to its previous close of 59.10. However, the company has experienced a 2.84% gain in its stock price over the last five trading sessions. proactiveinvestors.co.uk reported 2025-01-24 that Dr Martens PLC (LSE:DOCS) shares have been rising recently, a rare event since the iconic boot maker listed in 2021. New chief executive Ije Nwokorie, ex-Wolff Olins and Apple, came with a lot of goodwill and that has helped but next week’s update will be a more serious test.
DOCS’s Market Performance
DOCS’s stock has risen by 2.84% in the past week, with a monthly rise of 9.69% and a quarterly rise of 40.75%. The volatility ratio for the week is 3.17% while the volatility levels for the last 30 days are 3.36% for Doximity Inc The simple moving average for the past 20 days is 6.01% for DOCS’s stock, with a 50.42% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with Stephens repeating the rating for DOCS by listing it as a “Equal-Weight.” The predicted price for DOCS in the upcoming period, according to Stephens is $55 based on the research report published on December 20, 2024 of the previous year 2024.
Mizuho, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $55. The rating they have provided for DOCS stocks is “Neutral” according to the report published on December 04th, 2024.
Goldman gave a rating of “Neutral” to DOCS, setting the target price at $58 in the report published on November 15th of the previous year.
DOCS Trading at 8.02% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.86% of loss for the given period.
Volatility was left at 3.36%, however, over the last 30 days, the volatility rate increased by 3.17%, as shares surge +6.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.01% upper at present.
During the last 5 trading sessions, DOCS rose by +2.84%, which changed the moving average for the period of 200-days by +133.23% in comparison to the 20-day moving average, which settled at $55.42. In addition, Doximity Inc saw 10.04% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from TIMOTHY CABRAL, who proposed sale 20,000 shares at the price of $57.62 back on Feb 03 ’25. After this action, TIMOTHY CABRAL now owns shares of Doximity Inc, valued at $1,152,497 using the latest closing price.
Bryson Anna, the Chief Financial Officer of Doximity Inc, sale 100,000 shares at $58.42 during a trade that took place back on Nov 12 ’24, which means that Bryson Anna is holding 304,506 shares at $5,842,248 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.39 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.34. The total capital return value is set at 0.2. Equity return is now at value 19.00, with 16.24 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 16.7.
Currently, EBITDA for the company is 182.08 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 20.89. The receivables turnover for the company is 4.14for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.21.
Conclusion
To sum up, Doximity Inc (DOCS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.